Abstract
The promise and hopes that gene therapy vectors derived from adeno-associated virus (AAV) will make the leap from the laboratory bench to the clinic bedside are thoroughly described in this volume of Current Topics of Microbiology and Immunology. As more investigators enter this rapidly growing field, AAV’s ability to deliver genes of therapeutic potential will be explored for many acquired and hereditary diseases. AAV has several characteristics that make it an appealing human gene therapy vector: (1) the virus is naturally defective in that it requires the help of a coinfecting virus, usually adenovirus, for it to efficiently complete its life cycle, (2) in the absence of helper virus infection, AAV establishes a lysogenic state, usually in a site-specific locus on chromosome 19, (3) AAV is nonpathogenic because it has not been implicated as the causative agent of any known disease, (4) AAV’s small DNA genome (4680 nucleotides) allows for easy manipulation by standard recombinant DNA methodology. These characteristics have been described in other chapters of this volume but are briefly summarized here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alwine JC (1985) Transient gene expression control: effects of transfected DNA stability and trans-activation by viral early proteins. Mol Cell Biol 5: 1034–1042
Antoni BA, Rabson AB, Miller IL, Trempe JP, Chejanovsky N, Carter BJ (1991) Adeno-associated virus rep protein inhibits human immunodeficiency virus type 1 production in human cells. J Virol 65: 396–404
Bantel-Schaal U, zur Hausen H (1988) Adeno-associated viruses inhibit SV40 DNA amplification and replication of herpes simplex virus in SV40-transformed hamster cells. Virology 164: 64–74
Batchu RB, Kotin RM, Hermonat PL (1994) The regulatory rep protein of adeno-associated virus binds to sequences within the c-H-ras promoter. Cancer Lett 86: 23–31
Beaton A, Palumbo P, Berns KI (1989) Expression of the AAV p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol 63: 4450–4454
Becerra SP, Koczot F, Fabisch P, Rose JA (1988) Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript. J Virol 62: 2745–2754
Berkner KL (1992) Expression of heterologous sequences in adenoviral vectors. In: Muzyczka N (ed) Viral expression vectors. Springer, Berlin Heidelberg New York, pp 39–66 (Current topics in microbiology and immunology, vol 158)
Berns KI (1990) Parvoviridae and their replication: In: Fields BN, Knipe DM (eds) Virology, vol 2, 2nd edn. Raven, New York, pp 1743–1763
Bohinski RJ, Huffman JA, Whitsett JA, Lattier DL (1993) Cis-active elements controlling lung-specific expression of human pulmonary surfactant protein B genes. J Biol Chem 268: 11160–11166
Carter BJ, Laughlin CA, delaMaza LM, Myers M (1979) Adeno-associated virus autointerference. Virology 92: 449–462
Chejanovsky N, Carter BJ (1989) Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication. Virology 173: 120–128
Chiorini JA, Weitzman MD, Owens RA, Urcelay E, Safer B, Kotin RM (1994) Biologically active rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli. J Virol 68: 797–804
Curiel DT, Agarwal S, Wagner E, Cotten M (1991) Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc Natl Acad Sci USA 88: 8850–8854
delaMaza LM, Carter BJ (1978) DNA structure of incomplete adeno-associated virus particles. In: Ward DC, Tattersall P (eds) Replication of mammalian parvoviruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 193–204
Fisher KJ, Wilson JM (1994) Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer. Biochem J 299: 49–58
Flotte TR, Afione SA, Solow R, Drumm ML, Markakis D, Guggino WB, Zeitlin PL, Carter BJ (1993) Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem 268: 3781–3790
Georg-Fries B, Biederlack S, Wolf J, zur Hausen H (1984) Analysis of helper dependence, and seroepidemiology of a new human parvovirus. Virology 134: 64–71
Goodman S, Xiao X, Donahue RE, Moulton A, Miller J, Walsh C, Young NS, Samulski RJ, Nienhuis AW (1994) Recombinant adeno-associated virus mediated gene transfer into hematopoietic progenitor cells. Blood 84: 1492–1500
Graham FL, Smiley J, Russell WC, Naiva R (1977) Characteristics of a human cell line transformed by DNA from adenovirus type 5. J Gen Virol 36: 59–72
Heibronn R, Bürkle A, Stephan S, and zur Hausen (1990) The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J Virol 64: 3012–3018
Hermonat PL (1989) The adeno-associated virus rep78 gene inhibits cellular transformation by bovine papillomavirus. Virology 172: 253–261
Hermonat PL (1991) Inhibition of H-ras expression by the adeno-associated virus rep78 transformation suppressor gene product. Cancer Res 51: 3373–3377
Hermonat PL (1992) Inhibition of bovine papillomavirus plasmid DNA replication by adeno-associated virus. Virology 189: 329–333
Hermonat PL (1994) Down-regulation of the human c-fos and c-myc proto-oncogene promoters by adeno-associated virus Rep78. Cancer Lett 81: 129–136
Hermonat PL, Muzyczka N (1984) Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 81: 6466–6470
Hermonat PL, Labow MA, Wright R, Berns KI, Muzyczka N (1984) Genetics of adeno-associated virus: isolation and preliminary characterization of mutants of adeno-associated virus type 2. J Virol 51: 329–339
Hölscher C, Horker M, Kleinschmidt JA, Zentgraf H, Burkle A, Heilbronn R (1994) Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants. J Virol 68: 7169–7177
Khleif SN, Myers T, Carter BJ, Trempe JP (1991) Inhibition of cellular transformation by the adeno-associated virus rep gene. Virology 181: 738–741
Kotin RM (1994) Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther 5: 793–801
Kung H-J Boerkoel, Carter TH (1991) Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanisms of insertional activation. In: Kung HJ, Vogt PK (eds) Retroviral insertional mutagenesis and oncogene activation. Springer, Berlin Heidelberg New York, pp 1–24 (Current topics in microbiology and immunology, vol 171)
Kyöstiö SR, Owens RA, Weitzman MD, Antoni BA, Chejanovsky N, Carter BJ (1994) Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 NA levels. J Virol 68: 2947–2957
Labow MA, Graf LH, Berns KI (1987) Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes. Mol Cell Biol 7: 1320–1325
Labow MA, Berns KI (1988) The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. Mol Cell Biol 7: 1320–1325
Lebkowski JS, Mally MA, Okarma TB, Lerch LB (1988) Adeno-associated virus: A vector system for efficient introduction and integration of DNA into a variety of mammalian cells. Mol Cell Biol 8: 3988–3996
Mayor HD, Drake S, Stahmann J, Mumford DM (1976) Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. Am J Obstet Gynecol 126: 100–104
McLaughlin SK, Collis P, Hermonat PL, Muzyczka N (1988) Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 62: 1963–1973
Mendelson E, Miller IL, Carter BJ (1988a) Expression and rescue of a nonselected marker from an integrated AAV vector. Virology 166: 154–165
Mendelson E, Smith MG, Miller IL, Carter BJ (1988b) Effect of a viral rep gene on transformation of cells by an adeno-associated virus vector. Virology 166: 612–615
Miller JL, Donahue RE, Sellers SE, Samulski RJ, Young NS, Nienhuis AW (1994) Recombinant adeno-associated virus (AV)-mediated expression of a human g-globin gene in human progenitorderived erythroid cells. Pro Natl Acad Sci USA 91: 10183–10187
Morgan RA, Anderson WF (1993) Human gene therapy. Annu Rev Biochem 63: 191–217
Muzyczka N (1992) Use of adeno-associated virus as a general transduction vector for mammalian cells. In: Muzyczka N (ed) Viral expressions vectors. Springer, Berlin Heidelberg New York, pp 97–129 (Current topics in microbiology and immunology, vol 158)
Myers MW, Carter BJ (1980) Assembly of adeno-associated virus. Virology 102: 71–82
Ni T-H, Zhou X, Marty DM, Zolotukhin I, Muzyczka N (1994) In vitro replication of adeno-associated virus DNA. J Virol 68: 1128–1138
Owens RA, Trempe JP, Chejanovsky N, Carter BJ (1991) Adeno-associated virus rep proteins produced in insect and mammalian expression systems: wild-type and dominant-negative mutant proteins bind to the viral replication origin. Virology 184: 14–22
Parks WP, Boucher DW, Melnick JL, Taber LH, Yow MD (1970) Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses. Infect Immun 2: 716–722
Ruffing M, Zentgraf H, Kleinschmidt JA (1992) Assembly of virus-like particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J Virol 66: 6922–6930
Russell DW, Miller AD, Alexander IE (1994) Adeno-associated virus vectors preferentially transduce cells in S-phase. Proc Natl Acad Sci USA 91: 8915–8919
Samulski RJ (1993) Adeno-associated virus: integration at a specific chromosomal locus. Curr Opin Genet Devel 3: 74–80
Samulski RJ, Chang L-S, Shenk T (1987) A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol 61: 3096–3011
Samulski RJ, Chang L-S, Shenk T (1989) Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 63: 3822–3828
Samulski RJ, Xiao X, Kaplitt M, Leone Pfaff P, O’Malley K, During M (1994) Generation of AAV vectors for transduction and expression in neuronal cells in vivo. Gene therapy 21–25 Sept 1994, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (abstract)
Schlehofer JR, Ehrbar M, zur Hausen H (1986) Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helper virus dependent parvovirus. Virology 152: 110–117
Srivastava A, Lusby EW, Berns KI (1983) Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol 45: 555–564
Thomson BJ, Weindler FW, Gray D, Schwaab V, Heilbronn R (1994) Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression. Virology 204: 304–311
Tobiasch E, Rabreau M, Geletneky K, Larue-Charlus S, Severin F, Becker N, Schlehofer JR (1994) Detection of adeno-associated virus DNA in human genital tissue and in material from spontaneous abortion. J Med Virol 44: 215–222
Tratschin J-D, Miller IL, Carter BJ (1984a) Genetic analysis of adeno-associated virus: Property of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol 51: 611–619
Tratschin J-D, West MH, Sandbank T, Carter BJ (1984b) A human parvovirus, adeno-associated virus, as a eukaryotic vector: transient expression and encapsidation of the prokaryotic gene for chloramphenicol acetyltransferase. Mol Cell Biol 4: 2072–2081
Tratschin J-D, Miller IL, Smith MG, Carter BJ (1985) Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells. Mol Cell Biol 5: 3251–3260.
Tratschin J-D, Tal J, Carter BJ (1986) Negative and positive regulation intraris of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Mol Cell Biol 6: 2884–2894
Trempe JP, Carter BJ (1988) Regulation of adeno-associated virus gene expression in 293 cells: Control of NA abundance and translation. J Virol 62: 68–74
Vincent KA, Moore GK, Haigwood NI(1990) Replication and packaging of HIV envelope genes in a novel adeno-associated virus vector system. Vaccines 90: 350–353
Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler K, Curiel DT, Birnstiel M (1992) Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 89: 6099–6103
Winocour E, Callaham MF, Huberman E (1988) Perturbation of the cell cycle by adeno-associated virus. Virology 167: 393–399
Yakobson B, Koch T, Winocour E (1987) Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J Virol 61: 972–981
Yakobson B, Hrynko T, Peak MJ, Winocour E (1989) Replication of adeno-associated virus in cells irradiated with UV light at 254 nm. J Virol 63: 1023–1230
Yalkinoglu AO, Heilbronn R, Burkle A, Schlehofer JR, zur Hausen H (1988) DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res 48: 3123–3125
Yang Q, Chen F, Trempe JP (1994) Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J Virol 68: 4847–4856
Yang Q, Chen F, Ross J, Trempe JP (1995) Inhibition of Cellular and SV40 DNA Replication by the adeno-associated Virus Rep Proteins. Virology (in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Trempe, J.P. (1996). Packaging Systems for Adeno-associated Virus Vectors. In: Berns, K.I., Giraud, C. (eds) Adeno-Associated Virus (AAV) Vectors in Gene Therapy. Current Topics in Microbiology and Immunology, vol 218. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80207-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-80207-2_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80209-6
Online ISBN: 978-3-642-80207-2
eBook Packages: Springer Book Archive